The DOI matches its Crossref record; 426 of the 426 references it cites were found in a registry or an index.
Broad targeting of angiogenesis for cancer prevention and therapy
Open accessAbstract
Deregulation of angiogenesis--the growth of new blood vessels from an existing vasculature--is a main driving force in many severe human diseases including cancer. As such, tumor angiogenesis is important for delivering oxygen and nutrients to growing tumors, and therefore considered an essential pathologic feature of cancer, while also playing a key role in enabling other aspects of tumor pathology such as metabolic deregulation and tumor dissemination/metastasis. Recently, inhibition of tumor angiogenesis has become a clinical anti-cancer strategy in line with chemotherapy, radiotherapy and surgery, which underscore the critical importance of the angiogenic switch during early tumor development. Unfortunately the clinically approved anti-angiogenic drugs in use today are only effective in a subset of the patients, and many who initially respond develop resistance over time. Also, some of the anti-angiogenic drugs are toxic and it would be of great importance to identify alternative compounds, which could overcome these drawbacks and limitations of the currently available therapy. Finding "the most important target" may, however, prove a very challenging approach as the tumor environment is highly diverse, consisting of many different cell types, all of which may contribute to tumor angiogenesis. Furthermore, the tumor cells themselves are genetically unstable, leading to a progressive increase in the number of different angiogenic factors produced as the cancer progresses to advanced stages. As an alternative approach to targeted therapy, options to broadly interfere with angiogenic signals by a mixture of non-toxic natural compound with pleiotropic actions were viewed by this team as an opportunity to develop a complementary anti-angiogenesis treatment option. As a part of the "Halifax Project" within the "Getting to know cancer" framework, we have here, based on a thorough review of the literature, identified 10 important aspects of tumor angiogenesis and the pathological tumor vasculature which would be well suited as targets for anti-angiogenic therapy: (1) endothelial cell migration/tip cell formation, (2) structural abnormalities of tumor vessels, (3) hypoxia, (4) lymphangiogenesis, (5) elevated interstitial fluid pressure, (6) poor perfusion, (7) disrupted circadian rhythms, (8) tumor promoting inflammation, (9) tumor promoting fibroblasts and (10) tumor cell metabolism/acidosis. Following this analysis, we scrutinized the available literature on broadly acting anti-angiogenic natural products, with a focus on finding qualitative information on phytochemicals which could inhibit these targets and came up with 10 prototypical phytochemical compounds: (1) oleanolic acid, (2) tripterine, (3) silibinin, (4) curcumin, (5) epigallocatechin-gallate, (6) kaempferol, (7) melatonin, (8) enterolactone, (9) withaferin A and (10) resveratrol. We suggest that these plant-derived compounds could be combined to constitute a broader acting and more effective inhibitory cocktail at doses that would not be likely to cause excessive toxicity. All the targets and phytochemical approaches were further cross-validated against their effects on other essential tumorigenic pathways (based on the "hallmarks" of cancer) in order to discover possible synergies or potentially harmful interactions, and were found to generally also have positive involvement in/effects on these other aspects of tumor biology. The aim is that this discussion could lead to the selection of combinations of such anti-angiogenic compounds which could be used in potent anti-tumor cocktails, for enhanced therapeutic efficacy, reduced toxicity and circumvention of single-agent anti-angiogenic resistance, as well as for possible use in primary or secondary cancer prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ji, Q., Liu, X., Fu, X., Zhang, L., Sui, H., Zhou, L., Sun, J., Cai, J., Qin, J., Ren, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078700 · Cited by 354
RetractedEbrahimnezhad, Z., Zarghami, N., Keyhani, M., Amirsaadat, S., Rahmati, M., Mohammad Taheri, Z., & Nejati‐Koshki, K. (2013) · Europe PMC (PubMed Central) · doi:10.5681/bi.2013.005 · Cited by 75
RetractedTumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 3×
“nd perfusion in the tumor and thus reduce the pathological charcteristics of the vessels, for example via sub-maximal dosing of nti-angiogenic drugs [19].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 3×
“The switch depends on increased production of ne or more positive regulators of angiogenesis, such as vascuar endothelial growth factor (VEGF), fibroblast growth factor-2 FGF-2), interleukin-8 (IL-8), placental growth factor (PlGF), transorming growth factor-beta (TGFbeta), platelet derived growth actor (PDGF), angiop…”
BackgroundInfluentialBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Grothey, A., Cutsem, E. V., Sobrero, A., Siena, S., Falcone, A., Ychou, M., Humblet, Y., Bouché, O., Mineur, L., Barone, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61900-x · Cited by 2,895
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Motzer, R. J., Bander, N. H., & Nanus, D. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351207 · Cited by 2,219
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Klein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,543
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
(2000) · PubMed · Cited by 1,445
Carotenoid actions and their relation to health and disease
Krinsky, N. I., & Johnson, E. J. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.10.001 · Cited by 1,420
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
The perivascular niche regulates breast tumour dormancy
Ghajar, C. M., Peinado, H., Mori, H., Matei, I. R., Evason, K. J., Brazier, H., Almeida, D., Koller, A., Hajjar, K. A., Stainier, D. Y. R., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2767 · Cited by 1,148
Rotating night shifts and risk of breast cancer in women participating in the nurses׳ health study
Schernhammer, E. S., Laden, F., Speizer, F. E., Willett, W. C., Hunter, D. J., Kawachi, I., & Colditz, G. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1563 · Cited by 1,142
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2641 · Cited by 995
A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention
Chen, A. Y., & Chen, Y. C. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2012.11.139 · Cited by 994
Self-citationInhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986
Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter, I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2103 · Cited by 971
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
The lymphatic vasculature in disease
Alitalo, K. (2011) · Nature Medicine · doi:10.1038/nm.2545 · Cited by 962
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Guzy, R. D., & Schumacker, P. T. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033506 · Cited by 881
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study
Schernhammer, E. S., Laden, F., Speizer, F. E., Willett, W. C., Hunter, D. J., Kawachi, I., Fuchs, C. S., & Colditz, G. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.825 · Cited by 847
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041896 · Cited by 719
Why drinking green tea could prevent cancer
Jankun, J., Selman, S. H., Swiercz, R., & Skrzypczak-Jankun, E. (1997) · Nature · doi:10.1038/42381 · Cited by 718
Angiogenesis inhibited by drinking tea
Cao, Y., & Cao, R. (1999) · Nature · doi:10.1038/18793 · Cited by 688
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries
Siekmann, A. F., & Lawson, N. D. (2007) · Nature · doi:10.1038/nature05577 · Cited by 687
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3298 · Cited by 684
Rofstad, E. K., Mathiesen, B., Kindem, K., & Galappathi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0983 · Cited by 668
Kärpänen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Ylä‐Herttuala, S., Jäättelä, M., & Alitalo, K. K. (2001) · PubMed · Cited by 651
Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1272 · Cited by 640
Casazza, A., Laoui, D., Wenes, M., Rizzolio, S., Bassani, N., Mambretti, M., Deschoemaeker, S., Van Ginderachter, J. A., Tamagnone, L., & Mazzone, M. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.007 · Cited by 629
Multi-targeted therapy of cancer by genistein
Banerjee, S., Li, Y., Wang, Z., & Sarkar, F. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.052 · Cited by 620
Self-citationEffects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention
Ramos, S. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.11.004 · Cited by 617
Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 611
Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Forssell, J., Öberg, A., Henriksson, M. L., Stenling, R., Jung, A., & Palmqvist, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2073 · Cited by 566
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
García-Mediavilla, V., Crespo, I., Collado, P. S., Esteller, A., Sánchez-Campos, S., Tuñón, M. J., & González-Gallego, J. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.014 · Cited by 563
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Lu, K. V., Chang, J. P., Parachoniak, C. A., Pandika, M. M., Aghi, M. K., Meyronet, D., Isachenko, N., Fouse, S. D., Phillips, J. J., Cheresh, D. A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.037 · Cited by 550
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.
Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wähälä, K., Montesano, R., & Schweigerer, L. (1997) · PubMed · Cited by 534
VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., & Detmar, M. (2007) · Blood · doi:10.1182/blood-2006-05-021758 · Cited by 533
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Bishayee, A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0160 · Cited by 528
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
Cao, R., Björndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., Meister, B., Ikomi, F., Tritsaris, K., Dissing, S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.034 · Cited by 527
Klauber, N., Parangi, S., Flynn, E. A., Hamel, E., & D’Amato, R. J. (1997) · PubMed · Cited by 524
Hypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
Karagiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0307 · Cited by 507
Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Gotink, K. J., & Verheul, H. M. W. (2010) · Angiogenesis · doi:10.1007/s10456-009-9160-6 · Cited by 501
Milder, I. E. J., Arts, I. C. W., Putte, B. V. D., Venema, D. P., & Hollman, P. C. H. (2005) · British Journal of Nutrition · doi:10.1079/bjn20051371 · Cited by 498
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Meta-Analysis of Soy Intake and Breast Cancer Risk
Trock, B. J., Hilakivi-Clarke, L., & Clarke, R. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj102 · Cited by 468
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
Mäkinen, T., Adams, R. H., Bailey, J., Lu, Q., Ziemiecki, A., Alitalo, K., Klein, R., & Wilkinson, G. A. (2005) · Genes & Development · doi:10.1101/gad.330105 · Cited by 461
Phytoestrogen Content of Foods Consumed in Canada, Including Isoflavones, Lignans, and Coumestan
Thompson, L. U., Boucher, B. A., Liu, Z., Cotterchio, M., & Kreiger, N. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5402_5 · Cited by 449
Lin, Y. G., Kunnumakkara, A. B., Nair, A., Merritt, W. M., Han, L. Y., Armaiz-Pena, G. N., Kamat, A. A., Spannuth, W. A., Gershenson, D. M., Lutgendorf, S. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3072 · Cited by 440
Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo
Gou, M., Men, K., Shi, H., Xiang, M., Zhang, J., Song, J., Long, J., Wan, Y., Luo, F., Zhao, X., et al. (2011) · Nanoscale · doi:10.1039/c0nr00758g · Cited by 438
Mace, T. A., Ameen, Z., Collins, A., Wojcik, S., Mair, M., Young, G. S., Fuchs, J. R., Eubank, T. D., Frankel, W. L., Bekaii-Saab, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4601 · Cited by 410
Thomasset, S. C., Berry, D. P., Garcea, G., Marczylo, T., Steward, W. P., & Gescher, A. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22419 · Cited by 406
Curcumin Is an In Vivo Inhibitor of Angiogenesis
Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M.-T., Fisher, C., Flynn, E., & Byers, H. R. (1998) · Molecular Medicine · doi:10.1007/bf03401744 · Cited by 402
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12131 · Cited by 395
Redefining the Target: Chemotherapeutics as Antiangiogenics
Miller, K. D., Sweeney, C. J., & Sledge, G. W. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1195 · Cited by 395
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
Gardner, L. B., Li, Q., Park, M. S., Flanagan, W. M., Semenza, G. L., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010189200 · Cited by 390
Withaferin A is a potent inhibitor of angiogenesis
Mohan, R., Hammers, H., Bargagna-mohan, P., Zhan, X., Herbstritt, C., Ruiz, A., Zhang, L., Hanson, A., Conner, B., Rougas, J., et al. (2004) · Angiogenesis · doi:10.1007/s10456-004-1026-3 · Cited by 382
Siddiqui, I. A., Adhami, V. M., Bharali, D. J., Hafeez, B. B., Asim, M., Khwaja, S. I., Ahmad, N., Cui, H., Mousa, S. A., & Mukhtar, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3978 · Cited by 378
Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W. J., Lele, S. B., Morrison, C. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084941 · Cited by 364
Terpenoids as potential chemopreventive and therapeutic agents in liver cancer
Thoppil, R. J. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i9.228 · Cited by 353
Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M., & Aggarwal, B. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206048 · Cited by 353
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
Garvin, S., Öllinger, K., & Dabrosin, C. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.031 · Cited by 351
Self-citationSantini, D., Vincenzi, B., Dicuonzo, G., Avvisati, G., Massacesi, C., Battistoni, F., Gavasci, M., Rocci, L., Tirindelli, M. C., Altomare, V., et al. (2003) · PubMed · Cited by 350
Sun, R. C., & Denko, N. C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.022 · Cited by 344
Lund, A. W., Duraes, F. V., Hirosue, S., Raghavan, V. R., Nembrini, C., Thomas, S. N., Issa, A., Hugues, S., & Swartz, M. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.01.005 · Cited by 341
Mabjeesh, N. J., Post, D. E., Willard, M. T., Kaur, B., Meir, E. G. V., Simons, J. W., & Zhong, H. (2002) · PubMed · Cited by 338
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Mazur, W., Fotsis, T., Wähälä, K., Ojala, S., Salakka, A., & Adlercreutz, H. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0025 · Cited by 334
Brâkenhielm, E., Cao, R., & Cao, Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0028fje · Cited by 334
Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer
Bishayee, A. (2011) · Frontiers in Bioscience · doi:10.2741/3730 · Cited by 330
Jung, Y. D., Kim, M. S., Shin, B. A., Chay, K. O., Ahn, B. W., Liu, W., Bucana, C. D., Gallick, G. E., & Ellis, L. M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1691 · Cited by 329
Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves
Jayaprakasam, B., Zhang, Y., Seeram, N. P., & Nair, M. G. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.07.007 · Cited by 325
Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., Agarwal, M. L., & Mukhtar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206708 · Cited by 325
Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade
Lin, J.-K., Liang, Y.-C., & Lin-Shiau, S.-Y. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00112-4 · Cited by 324
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
Tosetti, F., Ferrari, N., De Flora, S., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0300rev · Cited by 324
Hepatocyte growth factor promotes lymphatic vessel formation and function
Kajiya, K., Hirakawa, S., Ma, B., Drinnenberg, I., & Detmar, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600763 · Cited by 322
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Kaelin, W. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-sup-040025 · Cited by 318
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
Cao, Y. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1693 · Cited by 307
Kubo, H., Cao, R., Bräkenhielm, E., Mäkinen, T., Cao, Y., & Alitalo, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062040199 · Cited by 305
Genistein, a Dietary Ingested Isoflavonoid, Inhibits Cell Proliferation and In Vitro Angiogenesis
Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R., & Schweigerer, L. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.3_suppl.790s · Cited by 305
Casagrande, F., & Darbon, J.-M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00583-4 · Cited by 303
Li, J.-L., Sainson, R. C. A., Shi, W., Leek, R., Harrington, L. S., Preusser, M., Biswas, S., Turley, H., Heikamp, E., Hainfellner, J. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0969 · Cited by 299
Wang, W., Li, Q., Yamada, T., Matsumoto, K., Matsumoto, I., Oda, M., Watanabe, G., Kayano, Y., Nishioka, Y., Sone, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1001 · Cited by 297
Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25938 · Cited by 289
Huang, Y. ‐., Hwang, J. ‐., Lee, P. ‐., Ke, F. ‐., Huang, J. ‐., Huang, C. ‐., Kandaswami, C., Middleton, E., & Lee, M. ‐. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702879 · Cited by 287
Nagaraj, S., Youn, J.-I., Weber, H., Iclozan, C., Lu, L., Cotter, M. J., Meyer, C., Becerra, C. R., Fishman, M., Antonia, S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3272 · Cited by 286
Nicolini, A., Carpi, A., & Rossi, G. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.07.002 · Cited by 279
Dose-dependent response of FGF-2 for lymphangiogenesis
Chang, L. K., Garcia-Cardeña, G., Farnebo, F., Fannon, M., Chen, E. J., Butterfield, C., Moses, M. A., Mulligan, R. C., Folkman, J., & Kaipainen, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404272101 · Cited by 276
Resveratrol and cellular mechanisms of cancer prevention
Shukla, Y., & Singh, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05870.x · Cited by 271
Shanmugam, M. K., Dai, X., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.016 · Cited by 271
Jang, J.-Y., Lee, J.-K., Jeon, Y.-K., & Kim, C.-W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-421 · Cited by 270
Malik, F., Kumar, A., Bhushan, S., Khan, S., Bhatia, A., Suri, K. A., Qazi, G. N., & Singh, J. (2007) · Apoptosis · doi:10.1007/s10495-007-0129-x · Cited by 254
Chronic Autophagy Is a Cellular Adaptation to Tumor Acidic pH Microenvironments
Wojtkowiak, J. W., Rothberg, J. M., Kumar, V., Schramm, K. J., Haller, E., Proemsey, J. B., Lloyd, M. C., Sloane, B. F., & Gillies, R. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3881 · Cited by 252
Suh, Y., Afaq, F., Johnson, J. J., & Mukhtar, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn269 · Cited by 251
Plant-derived phenolic antioxidants
Duthie, G., & Crozier, A. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200002000-00007 · Cited by 251
Lymphangiogenesis and lymphatic metastasis in breast cancer
Ran, S., Volk, L., Hall, K., & Flister, M. J. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.003 · Cited by 250
Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species
Hahm, E.-R., Moura, M. B., Kelley, E. E., Van Houten, B., Shiva, S., & Singh, S. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023354 · Cited by 248
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos, S., Fernández, R., Güezmes, A., & Sánchez‐Barceló, E. J. (1998) · PubMed · Cited by 246
Green Tea Inhibits Vascular Endothelial Growth Factor (VEGF) Induction in Human Breast Cancer Cells
Sartippour, M. R., Shao, Z.-M., Beatty, P., Zhang, L., Liu, C., Brooks, M. N., Heber, D., Ellis, L., Liu, W., & Go, V. L. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2307 · Cited by 245
VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors
Mattila, M. M., Ruohola, J. K., Karpanen, T., Jackson, D. G., Alitalo, K., & Härkönen, P. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10283 · Cited by 243
Zhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242
Self-citationDiabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock
Busik, J. V., Tikhonenko, M., Bhatwadekar, A., Opreanu, M., Yakubova, N., Caballero, S., Player, D., Nakagawa, T., Afzal, A., Kielczewski, J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090889 · Cited by 242
A direct and melanopsin-dependent fetal light response regulates mouse eye development
Rao, S., Chun, C., Fan, J., Kofron, J. M., Yang, M. B., Hegde, R. S., Ferrara, N., Copenhagen, D. R., & Lang, R. A. (2013) · Nature · doi:10.1038/nature11823 · Cited by 240
Lee, S. L. C., Rouhi, P., Jensen, L. D., Zhang, D., Ji, H., Hauptmann, G., Ingham, P., & Cao, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909228106 · Cited by 240
Self-citationWolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 236
Masuda, M., Suzui, M., Lim, J. T. E., Deguchi, A., Soh, J., & Weinstein, I. B. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01062.x · Cited by 235
Daurkin, I., Eruslanov, E., Stoffs, T., Perrin, G. Q., Algood, C., Gilbert, S. M., Rosser, C. J., Su, L.-M., Vieweg, J., & Kusmartsev, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1261 · Cited by 235
Koyanagi, S., Kuramoto, Y., Nakagawa, H., Aramaki, H., Ohdo, S., Soeda, S., & Shimeno, H. (2003) · PubMed · Cited by 234
Lockhart, A. C., Rothenberg, M. L., Dupont, J., Cooper, W., Chevalier, P., Sternas, L., Buzenet, G., Koehler, E., Sosman, J. A., Schwartz, L. H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9237 · Cited by 232
Agarwal, C., Singh, R. P., Dhanalakshmi, S., Tyagi, A. K., Tecklenburg, M., Sclafani, R. A., & Agarwal, R. (2003) · Oncogene · doi:10.1038/sj.onc.1207158 · Cited by 226
Yang, H., Shi, G., & Dou, Q. P. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030015 · Cited by 226
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225
Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids
Luo, H., Jiang, B.-H., King, S. M., & Chen, Y. C. (2008) · Nutrition and Cancer · doi:10.1080/01635580802100851 · Cited by 224
Self-citationTripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 224
Forty-Year Journey of Angiogenesis Translational Research
Cao, Y., Arbiser, J., D’Amato, R. J., D’Amore, P. A., Ingber, D. E., Kerbel, R., Klagsbrun, M., Lim, S., Moses, M. A., Zetter, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003149 · Cited by 223
Yang, C.-L., Liu, Y.-Y., Ma, Y.-G., Xue, Y.-X., Liu, D.-G., Ren, Y., Liu, X.-B., Li, Y., & Li, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037960 · Cited by 220
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Kulbe, H., Chakravarty, P., Leinster, D. A., Charles, K. A., Kwong, J., Thompson, R. G., Coward, J. I., Schioppa, T., Robinson, S. C., Gallagher, W. M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2178 · Cited by 220
van der Schaft, D. W. J., Seftor, R. E. B., Seftor, E. A., Hess, A. R., Gruman, L. M., Kirschmann, D. A., Yokoyama, Y., Griffioen, A. W., & Hendrix, M. J. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh267 · Cited by 219
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., & Tollefsbol, T. O. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21417 · Cited by 218
Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress
LaMonte, G., Tang, X., Chen, J. L.-Y., Wu, J., Ding, C.-K. C., Keenan, M. M., Sangokoya, C., Kung, H.-N., Ilkayeva, O., Boros, L. G., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-23 · Cited by 218
Circadian gene mPer2 overexpression induces cancer cell apoptosis
Hua, H., Wang, Y., Wan, C., Liu, Y., Zhu, B., Yang, C., Wang, X., Wang, Z., Cornelissen–Guillaume, G., & Halberg, F. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00225.x · Cited by 215
Self-citationHypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT)
Nishi, H., Nakada, T., Kyo, S., Inoue, M., Shay, J. W., & Isaka, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6076-6083.2004 · Cited by 213
Xue, Y., Lim, S., Yang, Y., Wang, Z., Jensen, L. D. E., Hedlund, E.-M., Andersson, P., Sasahara, M., Larsson, O., Galter, D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2575 · Cited by 212
Self-citationApte, R. N., Krelin, Y., Song, X., Dotan, S., Recih, E., Elkabets, M., Carmi, Y., Dvorkin, T., White, R. M., Gayvoronsky, L., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.010 · Cited by 211
Anticancer Therapeutic Potential of Soy Isoflavone, Genistein
Ravindranath, M. H., Muthugounder, S., Presser, N., & Viswanathan, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-4820-8_11 · Cited by 209
Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways
Onodera, Y., Nam, J.-M., & Bissell, M. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci63146 · Cited by 209
The Lymph Node as a Bridgehead in the Metastatic Dissemination of Tumors
Sleeman, J. P. (2000) · Recent Results in Cancer Research · doi:10.1007/978-3-642-57151-0_6 · Cited by 207
Matrix metalloproteinases: protective roles in cancer
Decock, J., Thirkettle, S., Wagstaff, L., & Edwards, D. R. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01302.x · Cited by 205
Wang, W., Feng, L., Yue, Q., Wu, W., Guan, S., Jiang, B., Yang, M., Liu, X., & Guo, D. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22956 · Cited by 205
A global clinical view on vitamin A and carotenoids
Sommer, A., & Vyas, K. S. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.034868 · Cited by 204
Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
Helfrich, I., Edler, L., Sucker, A., Thomas, M., Christian, S., Schadendorf, D., & Augustin, H. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1615 · Cited by 201
Christiansen, A., & Detmar, M. (2011) · Genes & Cancer · doi:10.1177/1947601911423028 · Cited by 200
Rattigan, Y. I., Patel, B. B., Ackerstaff, E., Sukenick, G., Koutcher, J. A., Glod, J. W., & Banerjee, D. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.014 · Cited by 196
Hypoxia response and microRNAs: no longer two separate worlds
Ivan, M., Harris, A. L., Martelli, F., & Kulshreshtha, R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00398.x · Cited by 193
Endogenous inhibitors of angiogenesis
Ribatti, D. (2009) · Leukemia Research · doi:10.1016/j.leukres.2008.11.019 · Cited by 191
Self-citationMartinive, P., Defresne, F., Bouzin, C., Saliez, J., Lair, F., Grégoire, V., Michiels, C., Dessy, C., & Feron, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2056 · Cited by 190
miRNAs as Modulators of Angiogenesis
Landskroner-Eiger, S., Moneke, I., & Sessa, W. C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006643 · Cited by 190
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer
Nakamura, Y., Yasuoka, H., Tsujimoto, M., Imabun, S., Nakahara, M., Nakao, K., Nakamura, M., Mori, I., & Kakudo, K. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-5783-x · Cited by 188
Maione, F., Capano, S., Regano, D., Zentilin, L., Giacca, M., Casanovas, O., Bussolino, F., Serini, G., & Giraudo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58976 · Cited by 187
Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts
Bhattacharyya, S., Md Sakib Hossain, D., Mohanty, S., Sankar Sen, G., Chattopadhyay, S., Banerjee, S., Chakraborty, J., Das, K., Sarkar, D., Das, T., et al. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.11 · Cited by 186
García-Maceira, P., & Mateo, J. (2009) · Oncogene · doi:10.1038/onc.2008.398 · Cited by 185
Plant-derived phenolic antioxidants
Duthie, G., & Crozier, A. (2000) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200011000-00006 · Cited by 183
Renyi-Vamos, F., Tovari, J., Fillinger, J., Timar, J., Paku, S., Kenessey, I., Ostoros, G., Agocs, L., Soltesz, I., & Dome, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1077 · Cited by 181
Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells
Madhok, B. M., Yeluri, S., Perry, S. L., Hughes, T. A., & Jayne, D. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605701 · Cited by 180
Touillaud, M. S., Thiebaut, A. C. M., Fournier, A., Niravong, M., Boutron-Ruault, M.-C., & Clavel-Chapelon, F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk096 · Cited by 180
Wang, X., Bai, H., Zhang, X., Liu, J., Cao, P., Liao, N., Zhang, W., Wang, Z., & Hai, C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt058 · Cited by 178
Self-citationKrueger, J., Liu, D., Scholz, K., Zimmer, A., Shi, Y., Klein, C., Siekmann, A., Schulte-Merker, S., Cudmore, M., Ahmed, A., et al. (2011) · Development · doi:10.1242/dev.063933 · Cited by 177
Gombos, Z., Xu, X., Chu, C. S., Zhang, P. J., & Acs, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1238 · Cited by 176
Kinugasa, Y., Matsui, T., & Takakura, N. (2014) · Stem Cells · doi:10.1002/stem.1556 · Cited by 175
Phytosterol Content in American Ginseng Seed Oil
Beveridge, T. H. J., Li, T. S. C., & Drover, J. C. G. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010701v · Cited by 174
High LYVE-1–Positive Lymphatic Vessel Numbers Are Associated with Poor Outcome in Breast Cancer
Bono, P., Wasenius, V.-M., Heikkilä, P., Lundin, J., Jackson, D. G., & Joensuu, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0826 · Cited by 173
Rofstad, E. K., Gaustad, J., Egeland, T. A. M., Mathiesen, B., & Galappathi, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25176 · Cited by 173
Cao, Z., Fang, J., Xia, C., Shi, X., & Jiang, B.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173
Lymphangiogenesis and cancer metastasis
Mumprecht, V., & Detmar, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00834.x · Cited by 171
Bertl, E., Bartsch, H., & Gerhäuser, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0324 · Cited by 169
Singh, B. N., Singh, B. R., Sarma, B. K., & Singh, H. B. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.05.007 · Cited by 168
Stanley, G., Harvey, K., Slivova, V., Jiang, J., & Sliva, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.116 · Cited by 168
Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice
Kuang, X., Yao, Y., Du, J. R., Liu, Y. X., Wang, C. Y., & Qian, Z. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.110 · Cited by 167
Pontiggia, O., Sampayo, R., Raffo, D., Motter, A., Xu, R., Bissell, M. J., de Kier Joffé, E. B., & Simian, M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166
Maeda-Yamamoto, M., Kawahara, H., Tahara, N., Tsuji, K., Hara, Y., & Isemura, M. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9811525 · Cited by 165
Vascular Hyperpermeability, Angiogenesis, and Stroma Generation
Nagy, J. A., Dvorak, A. M., & Dvorak, H. F. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006544 · Cited by 165
Cited by
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.008 · Cited by 515
Self-citationApplication of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
Lin, B., Song, X., Yang, D., Bai, D., Yao, Y., & Lu, N. (2018) · Gene · doi:10.1016/j.gene.2018.02.026 · Cited by 384
Xie, C., Wan, X., Quan, H., Zheng, M., Fu, L., Li, Y., & Lou, L. (2018) · Cancer Science · doi:10.1111/cas.13536 · Cited by 348
Metadata
- Authors
- Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., Chen, Y. C., Honoki, K., Fujii, H., Georgakilas, A. G., Nowsheen, S., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Helferich, B., Yang, X., Guha, G., Bhakta, D., Ciriolo, M. R., Aquilano, K., Chen, S., Halicka, D., Mohammed, S. I., Azmi, A. S., Bilsland, A., Keith, W. N., & Jensen, L. D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S224-S243
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2093412095
- Cited by
- 464
- References
- 426
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.